Comparing eptinezumab with onabotulinumtoxinA in the treatment of chronic migraine: a real-world evidence study

Comparing eptinezumab with onabotulinumtoxinA in the treatment of chronic migraine: a real-world evidence study

Abstract Background Migraine, a spectrum of episodic headache disorders common in the global population, may evolve into a very debilitating chronic condition, usually underdiagnosed, poorly recognized and difficult to manage. Neurotransmission in the trigeminovascular sensory nervous system, partic...

Full description

Saved in:
Bibliographic Details
Main Authors: Damiana Scuteri, Martina Pagliaro, Rosario Iannacchero, Michele Trimboli, Gary W. Lawrence, Giacinto Bagetta, Maria Tiziana Corasaniti
Format: Article
Language:English
Published: BMC 2025-07-01
Series:The Journal of Headache and Pain
Subjects:
Eptinezumab
OnabotulinutoxinA
Chronic migraine
Real-world
Pharmacovigilance
Efficacy
Online Access:https://doi.org/10.1186/s10194-025-02106-z
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s10194-025-02106-z

Similar Items